Labisto, Ellen Joy .
HRN: 23-39-41 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2023
CO-AMOXICLAV 625MG (TAB)
08/10/2023
08/17/2023
ORAL
625
BID
Msaf
Waiting Final Action